3DM 0.00% 0.0¢ 3d medical limited

M7T Post merger, page-13

  1. 45 Posts.
    Broker report April 2016.

    http://www.mach7t.com/wp-content/uploads/2016/04/M7T-Gordon-Capital-Report-April-2016.pdf

    BUSINESS DRIVERS & GROWTH PROFILE

    The rapid pace of change in patient healthcare is driving unprecedented innovation toward streamlining and unifying the current multi-platform offering Mach7 expects its initial revenue to be sourced from two key activities:

    • Licencing: medical imaging software solutions such as Mach7 VNA, EchoPixel and GestSure that value-add medical imaging data
    • Manufacturing: design and production of 3D-printed patient-specific anatomical objects (bio-models) built from medical imaging data

    The Company has identified key target markets for its products and services from radiology providers and medical specialists in such areas as cardiology, neurology, gastroenterology and orthopaedics.
 
watchlist Created with Sketch. Add 3DM (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.